MDL 25637
Latest Information Update: 20 Feb 1995
At a glance
- Originator Aventis
- Class Antihyperglycaemics
- Mechanism of Action Alpha-glucosidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 20 Feb 1995 Discontinued-I for Type-2 diabetes mellitus in USA (Unknown route)